Biodesix
Biodesix buys lung nodule test developer Integrated Diagnostics
Molecular diagnostics company Biodesix has acquired Integrated Diagnostics (Indi) and its complementary oncology product, the XL2 test, intended to improve…
Molecular diagnostics company Biodesix has acquired Integrated Diagnostics (Indi) and its complementary oncology product, the XL2 test, intended to improve…